Epstein-Barr Virus Vaccines

Jennifer M. Geris; Henry H. Balfour

doi:10.1016/B978-0-323-79058-1.00024-4

Epstein-Barr Virus Vaccines

Jennifer M. Geris
, Henry H. Balfour

Laboratory Medicine and Pathology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Epstein-Barr virus (EBV) is a ubiquitous human pathogen that infects >90% of adults worldwide. EBV is responsible for most cases of infectious mononucleosis, and is associated with the development of certain cancers and autoimmune diseases, especially multiple sclerosis. EBV vaccines could potentially eliminate or reduce the severity of all of these diseases. This chapter reviews the research on prophylactic and therapeutic EBV vaccines including a discussion of the barriers impacting their development.

Original language	English (US)
Title of host publication	Plotkin's Vaccines, Eighth Edition
Publisher	Elsevier
Pages	341-347
Number of pages	7
ISBN (Electronic)	9780323790581
ISBN (Print)	9780323790604
DOIs	https://doi.org/10.1016/B978-0-323-79058-1.00024-4
State	Published - Jan 1 2023

Bibliographical note

Publisher Copyright:
© 2023 Elsevier Inc. All rights reserved.

Keywords

Burkitt lymphoma
EBV vaccine
Epstein-Barr virus
Hodgkin lymphoma
infectious mononucleosis
multiple sclerosis
nasopharyngeal carcinoma
post-transplant lymphoproliferative disorder

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/B978-0-323-79058-1.00024-4

Find It

Find It at U of M Libraries

Cite this

@inbook{7ce4aa1211a64e2aaea76a91bf25156d,

title = "Epstein-Barr Virus Vaccines",

abstract = "Epstein-Barr virus (EBV) is a ubiquitous human pathogen that infects >90\% of adults worldwide. EBV is responsible for most cases of infectious mononucleosis, and is associated with the development of certain cancers and autoimmune diseases, especially multiple sclerosis. EBV vaccines could potentially eliminate or reduce the severity of all of these diseases. This chapter reviews the research on prophylactic and therapeutic EBV vaccines including a discussion of the barriers impacting their development.",

keywords = "Burkitt lymphoma, EBV vaccine, Epstein-Barr virus, Hodgkin lymphoma, infectious mononucleosis, multiple sclerosis, nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder",

author = "Geris, \{Jennifer M.\} and Balfour, \{Henry H.\}",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-79058-1.00024-4",

language = "English (US)",

isbn = "9780323790604",

pages = "341--347",

booktitle = "Plotkin's Vaccines, Eighth Edition",

publisher = "Elsevier",

}

TY - CHAP

T1 - Epstein-Barr Virus Vaccines

AU - Geris, Jennifer M.

AU - Balfour, Henry H.

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Epstein-Barr virus (EBV) is a ubiquitous human pathogen that infects >90% of adults worldwide. EBV is responsible for most cases of infectious mononucleosis, and is associated with the development of certain cancers and autoimmune diseases, especially multiple sclerosis. EBV vaccines could potentially eliminate or reduce the severity of all of these diseases. This chapter reviews the research on prophylactic and therapeutic EBV vaccines including a discussion of the barriers impacting their development.

AB - Epstein-Barr virus (EBV) is a ubiquitous human pathogen that infects >90% of adults worldwide. EBV is responsible for most cases of infectious mononucleosis, and is associated with the development of certain cancers and autoimmune diseases, especially multiple sclerosis. EBV vaccines could potentially eliminate or reduce the severity of all of these diseases. This chapter reviews the research on prophylactic and therapeutic EBV vaccines including a discussion of the barriers impacting their development.

KW - Burkitt lymphoma

KW - EBV vaccine

KW - Epstein-Barr virus

KW - Hodgkin lymphoma

KW - infectious mononucleosis

KW - multiple sclerosis

KW - nasopharyngeal carcinoma

KW - post-transplant lymphoproliferative disorder

UR - https://www.scopus.com/pages/publications/85211416038

UR - https://www.scopus.com/pages/publications/85211416038#tab=citedBy

U2 - 10.1016/B978-0-323-79058-1.00024-4

DO - 10.1016/B978-0-323-79058-1.00024-4

M3 - Chapter

AN - SCOPUS:85211416038

SN - 9780323790604

SP - 341

EP - 347

BT - Plotkin's Vaccines, Eighth Edition

PB - Elsevier

ER -

Epstein-Barr Virus Vaccines

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this